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Abstract: In the pulmonary vasculature, mechanical forces such as cyclic stretch induce 
changes in vascular signaling, tone and remodeling. Nitric oxide is a potent regulator of 
soluble guanylate cyclase (sGC), which drives cGMP production, causing vasorelaxation. 
Pulmonary artery smooth muscle cells (PASMCs) express inducible nitric oxide synthase 
(iNOS), and while iNOS expression increases during late gestation, little is known about how 
cyclic stretch impacts this pathway. In this study, PASMC were subjected to cyclic stretch of 
20% amplitude and frequency of 1 Hz for 24 h and compared to control cells maintained 
under static conditions. Cyclic stretch significantly increased cytosolic oxidative stress as 
compared to static cells (62.9 ± 5.9% vs. 33.3 ± 5.7% maximal oxidation), as measured by 
the intracellular redox sensor roGFP. Cyclic stretch also increased sGCβ protein expression 
(2.5 ± 0.9-fold), sGC activity (1.5 ± 0.2-fold) and cGMP levels (1.8 ± 0.2-fold), as well as 
iNOS mRNA and protein expression (3.0 ± 0.9 and 2.6 ± 0.7-fold, respectively) relative to 
control cells. An antioxidant, recombinant human superoxide dismutase (rhSOD), 
significantly decreased stretch-induced cytosolic oxidative stress, but did not block  
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stretch-induced sGC activity. Inhibition of iNOS with 1400 W or an iNOS-specific siRNA 
inhibited stretch-induced sGC activity by 30% and 68% respectively vs. static controls. In 
conclusion, cyclic stretch increases sGC expression and activity in an iNOS-dependent 
manner in PASMC from fetal lambs. The mechanism that produces iNOS and sGC 
upregulation is not yet known, but we speculate these effects represent an early compensatory 
mechanism to counteract the effects of stretch-induced oxidative stress. A better 
understanding of the interplay between these two distinct pathways could provide key 
insights into future avenues to treat infants with pulmonary hypertension. 
Keywords: pulmonary vasculature; cyclic stretch; sGC; reactive oxygen species; iNOS 
 
1. Introduction 
At the time of transition from the fetal to neonatal pattern of circulation, blood vessels in the 
neonatal pulmonary vasculature are acutely exposed to mechanical forces such as shear stress from the 
movement of circulating blood, intra-luminal stretch determined by pressure from heart propulsions, 
and extra-luminal stretch induced by respiratory cycles. Cyclic stretch (CS) alters intracellular 
signaling, leading to changes in vascular tone, often by the production of vasoactive molecules. 
Physiologic levels of cyclic stretch can also promote vascular remodeling by inhibiting apoptosis in the 
vascular endothelium and causing mitotic arrest of vascular smooth muscle cells. Recent reports 
suggest that pathologic levels of stretch increase production of reactive oxygen species (ROS) via 
increased NADPH oxidase activity. These ROS may in turn trigger vasoconstriction in chronic 
hypertension, stimulate vascular remodeling or angiogenesis, or induce vascular barrier dysfunction in 
the pulmonary circulation damaged by ventilator-induced lung injury [1,2].  
Nitric oxide (NO), a well-studied vasodilator molecule in the pulmonary vasculature, is produced 
by nitric oxide synthase (NOS) by conversion of L-arginine to L-citrulline, and activates soluble 
guanylate cyclase (sGC) to increase levels of cyclic guanine monophosphate (cGMP), ultimately 
causing vasorelaxation. Three distinct isoforms of NOS have been identified: neuronal NOS (nNOS, 
NOS I), inducible NOS (iNOS, NOS II) and endothelial NOS (eNOS, NOS III). Past studies presumed 
eNOS to be the predominant source of NO production in the pulmonary vasculature; however, more 
recent studies suggest that iNOS is an important isoform in generating the NO-mediated fall in 
pulmonary vascular resistance during the transition of pulmonary circulation from fetal to neonatal  
life [3]. The iNOS isoform has been shown to be expressed in the airway epithelium and vascular 
smooth muscle in late-gestation ovine fetal lung, and some groups speculate that cyclic stretch and 
increased oxygen exposure of distal airway epithelium may directly activate iNOS, leading to 
vasorelaxation [3,4]. 
Recent studies from a lamb model of persistent pulmonary hypertension of the newborn (PPHN) 
suggest that pulmonary vascular sGC activity is diminished [5–7]. Furthermore, PPHN lambs  
exhibit increased ROS and NADPH oxidase expression [8–11], which are thought to lead to  
vasoconstriction [9,11,12]. Given these findings, we were surprised to find that PPHN lambs also have 
markedly increased iNOS protein expression [13]. In the adult systemic vasculature, ROS have also 
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been shown to decrease the expression and activity of sGCβ, the heme-binding subunit of sGC [12]. 
Thus, we hypothesized that pathologic cyclic stretch as seen in PPHN leads to increased levels of 
pulmonary vascular ROS, which would in turn decrease sGC expression and activity. Similar to our 
findings in intact lambs, we now show that in isolated fetal pulmonary artery smooth muscle cells 
(PASMC), cyclic stretch induces both cytosolic ROS and iNOS expression. However, in contrast to 
our hypothesis, we found that stretch increased sGCβ expression and activity in PASMC. Furthermore, 
treatment with recombinant human superoxide dismutase (rhSOD) did not block stretch-induced sGC 
activity. Instead, inhibition of iNOS with either a potent and selective inhibitor (1400 W) or iNOS 
siRNA was sufficient to completely block stretch-induced sGC activity, suggesting stretch-induced 
changes in iNOS activity are responsible for the changes in sGC activity and that these changes are 
independent of stretch-induced ROS. 
2. Results 
2.1. Cytosolic Oxidant Stress Is Increased in PASMC Exposed to Cyclic Stretch 
Previous studies have suggested that fetal and neonatal lambs with chronic intrauterine  
pulmonary hypertension exhibit increased ROS in their pulmonary arteries [8,13]. Thus, we sought to 
determine if an in vitro model of cyclic stretch would directly increase oxidative stress in PASMC. 
PASMC exposed to cyclic stretch for 24 h demonstrated a significant increase in cytosolic oxidant 
stress as measured by the redox-sensitive probe roGFP (Figure 1; stretch vs. static: 62.9% ± 5.9% vs.  
33.3% ± 5.7% oxidized).  
Figure 1. Pulmonary artery smooth muscle cells (PASMCs) exposed to 24 h cyclic stretch 
have increased oxidative stress in the cytosol. Ovine PASMC were isolated from healthy 
lambs and exposed to cyclic stretch in vitro. Oxidant stress was measured as the  
% maximal oxidation of the RoGFP probe. Data are shown as mean ± SEM (n = 9 for 
static, n = 6 for stretch). * p < 0.05. 
 
2.2. rhSOD Does not Block Stretch-Induced Increase in sGC Activity  
To determine if the stretch-induced ROS would directly impact sGC activity, we measured both 
oxidative stress and sGC activity in the presence of the antioxidant, rhSOD. rhSOD blocked  
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stretch-induced cytosolic oxidative stress (Figure 2A; rhSOD-treated stretched PASMC  
[1.0 ± 0.1-fold] vs. untreated stretched PASMC [1.9 ± 0.1-fold]). However, cyclic stretch for 24 h 
induced sGC activity in untreated PASMC (Figure 2B; 2.3 ± 0.5-fold vs. untreated static PASMC), but 
rhSOD had no impact on the cyclic-stretch induced sGC activity (Figure 2B).  
Figure 2. Recombinant human superoxide dismutase (rhSOD) abrogates stretch-induced 
cytosolic oxidative stress but not soluble guanylate cyclase (sGC) activity in PASMC. 
Ovine PASMC were isolated from healthy lambs and exposed to cyclic stretch in vitro for 
24 h. (A) Oxidant stress measured in the untreated cells is shown with the black bars, and 
the cells treated with rhSOD (20 units/mL) are shown with the white bars. Oxidant stress 
was measured as the % maximal oxidation of the RoGFP probe. Data are shown as  
mean ± SEM-fold relative to static untreated cells (n = 3). * p < 0.05 vs. untreated static,  
# p < 0.05 vs. untreated stretch. (B) sGC activity measured in the untreated cells is shown 
with the black bars, and the cells treated with rhSOD (20 units/mL) are shown with the 
white bars. sGC activity was measured as previously described. Data are shown as  
mean ± SEM (n = 9 for static untreated and stretch + rhSOD, n = 8 for static+rhSOD and 
stretch untreated). * p < 0.05 vs. untreated static. 
 
2.3. sGC Expression and Activity Is Increased in PASMC Exposed to Cyclic Stretch  
Previous studies in adult systemic SMC and in fetal and lamb resistance pulmonary arteries suggest 
that elevated ROS are associated with decreased sGC expression and activity [7,12,14]. Thus, we 
measured sGC expression and activity after exposure to cyclic stretch. PASMC exposed to 24 h of 
cyclic stretch had increased sGCβ expression (Figure 3A; 2.5 ± 0.9-fold). A representative Western 
Blot is shown in Figure 3B. Accordingly, we also show that sGC activity increases following exposure 
to cyclic stretch (Figure 3C; 1.5 ± 0.2-fold). Consistent with increased sGC activity, we note increased 
cGMP levels in the PASMC exposed to 24 h of cyclic stretch vs. static PASMC (Figure 3D; 0.9 ± 0.1 
vs. 0.5 ± 0.1 pmol cGMP/mg protein). Finally, we demonstrate that 24 h of cyclic stretch does not 
impact PDE5 protein expression (Figure 3E,F) or PDE5 specific activity (Figure 3G). 
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Figure 3. PASMC exposed to 24 h cyclic stretch have increased sGC expression and 
activity. Ovine PASMC were isolated from healthy lambs and exposed to cyclic stretch  
in vitro. (A) sGCβ protein expression was analyzed via Western blot, with β-actin 
normalization. Data are shown as mean ± SEM relative to static cells (n = 6).  
(B) Representative Western blot for sGCβ expression. (C) sGC activity was measured as 
previously described, and data are expressed as pmol cGMP produced/mg protein/min. 
Data are shown as mean ± SEM (n = 24). * p < 0.05. (D) cGMP levels were measured as 
previously described, and data are expressed as pmol cGMP/mg protein. Data are shown as 
mean ± SEM (n = 6). * p < 0.05. (E) PDE5 protein expression was analyzed via Western 
blot, with β-actin normalization. Data are shown as mean ± SEM relative to static cells  
(n = 6). (F) Representative Western blot for PDE5 expression. (G) PDE5 specific activity 
was measured as previously described, and data are expressed as pmol cGMP 
hydrolyzed/mg protein/min. Data are shown as mean ± SEM (n = 7). 
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2.4. iNOS mRNA and Protein Expression Is Increased in PASMC Exposed to Cyclic Stretch 
We have previously demonstrated that lambs with chronic intrauterine pulmonary hypertension 
have increased iNOS expression, and others have previously shown mechanical stretch can induce 
iNOS expression and activity in bronchial or synovial cells [15,16]. Thus, we sought to determine if 
iNOS activity is directly responsible for the stretch-mediated changes in sGC activity. PASMC 
exposed to 24 h of cyclic stretch had a trend towards increased iNOS mRNA expression (Figure 4A; 
3.0 ± 0.9-fold, p = 0.06) and significantly increased iNOS protein expression (Figure 4B;  
2.6 ± 0.7-fold, p < 0.05). 
Figure 4. PASMC exposed to 24 h of cyclic stretch have increased inducible nitric oxide 
synthase (iNOS) mRNA and protein expression. Ovine PASMC were isolated from healthy 
lambs and exposed to cyclic stretch in vitro. (A) iNOS mRNA expression is shown with 
the black bars. iNOS mRNA expression was measured via real-time PCR normalized to  
β-actin. Data are shown as mean ± SEM-fold relative to static cells (n = 3). (B) iNOS 
protein expression was analyzed via Western blot, with β-actin normalization (n = 14). 
Data are shown as mean ± SEM relative to static cells. * p < 0.05. 
 
2.5. iNOS Inhibition with 1400 W and iNOS-Specific siRNA Blocks Stretch-Induced sGC Activity  
The specific iNOS inhibitor, 1400 W, led to a 30% decrease in sGC activity in PASMC exposed to 
24 h of cyclic stretch vs. vehicle-treated PASMC exposed to cyclic stretch (Figure 5). Transfection 
with iNOS-specific siRNA led to a 58% knockdown in iNOS expression (Figure 6A) and led to a 68% 
decrease in sGC activity in PASMC exposed to 24 h of cyclic stretch vs. scrambled control  
(Figure 6C). A representative Western Blot for iNOS knockdown in PASMC is shown in Figure 6B. 
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Figure 5. An iNOS inhibitor, 1400 W, decreased sGC activity in PASMC exposed to 24 h 
of cyclic stretch. Ovine PASMC were isolated from healthy lambs and exposed to cyclic 
stretch in vitro. sGC activity measured in the untreated cells is shown with the black bars 
and in the cells treated with 1400 W (500 nM) is shown with the white bars. sGC activity 
was measured as previously described. Data are shown as mean ± SEM relative to 
untreated, static cells (n = 13). * p < 0.05 vs. untreated static. 
 
Figure 6. An iNOS-specific siRNA decreased sGC activity in PASMC exposed to 24 h of 
cyclic stretch. Ovine PASMC were isolated from healthy lambs and exposed to cyclic 
stretch in vitro. (A) iNOS protein expression was analyzed via Western blot, with β-actin 
normalization, in static PASMC (n = 7). * p < 0.05. (B) Representative Western blot for 
iNOS expression in static PASMC treated with an iNOS-specific siRNA. Lane 1 represents 
scrambled controls and Lane 2 represents PASMC treated with iNOS-specific siRNA.  
(C) sGC activity measured in the scrambled controls is shown with the black bars and in 
the cells treated with an iNOS-specific siRNA (100 nM) is shown with the white bars. sGC 
activity was measured as previously described (n = 6). * p < 0.05 vs. untreated static,  
# p < 0.05 vs. untreated stretch. 
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3. Discussion 
The exposure of blood vessels to mechanical stress is thought to play an important role in vascular 
remodeling in both normal physiologic adaptation, such as the neonatal transition to ex-utero life, and 
in pathological conditions, such as hypertension, atherosclerosis and diabetes [1]. The two main 
mechanical forces acting on the blood vessel walls are stretch and shear stress from the movement of 
blood through the vessel lumen. In both the systemic and pulmonary circulation, mechanical stretch 
exerts its effects through the combined action of pulsatile and tonic components. The tonic component 
is derived from the baseline contractility of vascular smooth muscle cells, while the pulsatile 
component is derived from cyclic mechanical strain that is imposed by the heart propulsions. 
Physiological levels of cyclic stretch are thought to be essential for the maintenance of the vascular 
smooth muscle cell contractile phenotype, the regulation of vascular tone, and the expression of native 
constituents of the vascular wall extracellular matrix [1]. 
Vascular stretch has also been shown to stimulate the generation of ROS by activation of  
redox-sensitive signaling pathways [1]. Superoxide appears to be the initial species generated in these 
cell types. The potential sources associated with the increased superoxide production include the 
family of NADPH oxidases, the mitochondrial electron transport chain, and the xanthine oxidase 
system. In addition, ROS production by the “uncoupling” of NOS activity has been implicated in the 
pathogenesis of pulmonary hypertension [1,17]. However, it is not clear which of these potential 
sources are activated directly by cyclic stretch. 
The NO-sGC-cGMP signaling pathway has been implicated in many physiological processes 
including cell growth and proliferation and vascular homeostasis. sGC contains a prosthetic ferrous 
heme group that binds NO with very high affinity. When NO binds to the enzyme’s heme moiety, a 
conformational change occurs, leading to a 200-fold increase in the enzyme’s production of cGMP, 
which then acts as a second messenger to mediate vascular relaxation through the activation of a 
cGMP-specific protein kinase [18]. At physiological levels of NO, superoxide has been shown to 
attenuate the actions of NO by reacting with it to generate peroxynitrite in amounts that are likely to 
have multiple biological effects such as oxidizing the heme moiety of sGC, thereby rendering it 
unresponsive to NO-stimulation [18]. 
Thus, based on the ample evidence for increased ROS and decreased sGC activity in intact lambs 
with PPHN [7,8], we hypothesized that mechanical stretch applied to an in vitro cell culture model 
would increase ROS, and would decrease sGC expression and activity in our PASMC. Surprisingly, 
we instead demonstrated that 24 h of exposure to cyclic stretch increased both the expression and 
activity of sGC. These findings represent the first report of stretch-mediated upregulation of sGC 
expression and activity. Consistent with this upregulation of sGC activity, we see increased cGMP 
levels. Interestingly, we saw no change in PDE5 expression or activity in the PASMC exposed to 
cyclic stretch. This suggests that the stretch-mediated changes in sGC are primarily responsible for the 
observed changes in cGMP. One key difference between our cell studies and the intact lamb studies 
was the duration of exposure. We exposed our cells to 24 h of cyclic stretch whereas the lambs had 
their ductus arteriosus ligated 9–14 days prior to delivery, leading to a more prolonged exposure to the 
mechanical strain associated with pulmonary hypertension. Additionally, in the intact lamb, there are 
endothelial cells present, which may or may not respond similarly to isolated PASMC. Thus, we 
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speculate that the increase in sGC expression and activity we observed in this study could represent an 
early compensatory response in the smooth muscle to increased ROS. Over the prolonged time of 
mechanical strain in the PPHN lambs, increased iNOS and superoxide generate peroxynitrite, which 
can subsequently inactivate sGC. Hence, with a prolonged exposure to mechanical stretch, this 
compensatory response is likely lost due to ROS-mediated targeting of sGC for degradation [12]. 
Since stretch-induced sGC activity was not dependent on ROS in our PASMC, we sought to 
determine what might be upstream of sGC. sGC expression and activity is well-known to be regulated 
by NO derived from eNOS [19]. However, our isolated PASMC do not express eNOS, but they do 
express iNOS and nNOS [13]. Rairigh et al. have suggested that iNOS may be an important 
contributor to the basal production of NO and modulation of basal vascular tone in the normal  
late-gestation fetal circulation [20]. iNOS is distinct from other isoforms of NOS as its activity is 
independent of intracellular calcium. Additionally, iNOS is regulated at a transcriptional level 
primarily through induction by endotoxin and cytokines and is associated with inflammatory  
states [20]. Interestingly, we have previously demonstrated that PPHN lambs exhibit increased iNOS 
expression [13]. Others have also demonstrated that cyclic stretch can increase iNOS expression and 
activity in multiple other cell types [15,16,21]. We now report that in fetal lamb PASMC exposed to 
24 h of cyclic stretch, iNOS mRNA and protein expression are up-regulated. We also demonstrate that 
inhibition of iNOS using either 1400 W, a potent and selective inhibitor of iNOS, or an iNOS-specific 
siRNA, attenuates stretch-induced sGC activity. We propose that mechanical strain activates iNOS in 
PASMC, and that increased NO serves to up-regulate sGC activity (Figure 7). These data are in 
contrast to previously published data that hypoxia induces sGC expression in an iNOS-independent 
manner in a mouse model of pulmonary hypertension, and highlight that distinct mechanisms may 
induce pulmonary hypertension under these differing conditions [22].  
Figure 7. Proposed model for effects of cyclic stretch on ROS and sGC in PASMC. Cyclic 
stretch increases both cytosolic ROS and sGC expression and activity. The stretch-induced 
increase in ROS is blocked by rhSOD. The stretch-induced increase in sGC activity is 
attenuated by 1400 W, a selective iNOS inhibitor, and iNOS-specific siRNA but not 
rhSOD, suggesting that the stretch-induced changes in sGC are dependent on iNOS and 
independent of cytosolic ROS. 
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4. Experimental Section  
4.1. Cell Culture  
Primary cultures of ovine PASMC from healthy sheep were isolated and grown to confluence and 
maintained in DMEM with glucose (Mediatech, Herndon, VA, USA), 10% fetal bovine serum 
(Hyclone, Logan, UT, USA), antibiotics and antimycotics (Mediatech) at 37 °C in 21% O2–5% CO2. 
All experiments were carried out using cells that were less than passage 8, and all experiments were 
performed with cells isolated from multiple different animals [23]. PASMC were cultured on 6-well 
BioFlex plates coated with collagen type I (FlexCell, Hillsborough, NC, USA) for 24–48 h. Some cell 
cultures were treated with recombinant human superoxide dismutase (rhSOD, 20 units/mL diluted in 
PBS, Sigma, St. Louis, MO, USA), a pharmacologic iNOS inhibitor (1400 W, 500 nM diluted in PBS, 
Calbiochem, Billerica, MA, USA) or transfected with an iNOS-specific siRNA (100 nM, Invitrogen, 
Grand Island, NY, USA), and were synchronized prior to the experiment by transfer to serum-free 
DMEM with antibiotics and antimycotics (Mediatech) prior to the start of cyclic stretch. All untreated 
cells were treated with the appropriate vehicle (PBS for rhSOD and 1400 W) or transfected with 
scrambled control siRNA. These cultures were then subjected to biaxial cyclic stretch using the 
FlexCell 3000 Strain Unit. Plates were placed on a loading station and stretched by applying an 
oscillatory vacuum to the underside of the membranes with a frequency of 1 Hz and 20% amplitude for 
24 h [24]. PASMC were then harvested, and oxidative stress and sGC activity was measured as 
described below. 
4.2. Transfection with iNOS-Specific siRNA 
PASMC were cultured on Bioflex plates as described above. For transfection assay, 10 µL of an 
iNOS-specific siRNA (50 µM stock diluted in nuclease-free water, Invitrogen) or scrambled control 
(50 µM stock diluted in nuclease-free water, Invitrogen) was incubated with 17.5 µL Lipofectamine 
RNAimax reagent (10 µM stock diluted in nuclease-free water, Invitrogen) in 1.4 mL serum-free 
DMEM for 20 min at room temperature. Each well of cells received 200 µL of either the  
iNOS-specific siRNA-transfection mixture or the scrambled control and 500 µL serum-free DMEM 
such that the final concentration of siRNA or scrambled control was 100 nM; cells were incubated 
with this transfection mixture for 4–6 h. The cells were then incubated with complete DMEM, and  
48 h after transfection, cells were changed to serum-free DMEM with antibiotics and antimycotics and 
subjected to either cyclic stretch or maintained in static conditions at 37 °C in 21% O2–5% CO2 for  
24 h. PASMC were then harvested, and sGC activity and iNOS expression were measured as  
described below. 
4.3. Detection of Reactive Oxygen Species (ROS) 
PASMC were infected with 100 PFU/cell of a cytosolic roGFP adenoviral construct. RoGFP is a 
previously characterized ratiometric fluorescent probe sensitive to cellular oxidative stress [23,25]. To 
create this probe, surface-exposed residues in green fluorescent protein (GFP) were replaced with 
cysteine residues capable of forming disulfide bonds. Assessment of fluorescence ratios provides a 
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real-time measure of cysteine thiol redox status in live cells. Ro-GFP infected PASMC were exposed 
to cyclic stretch or static conditions at 37 °C in 21% O2–5% CO2 for 24 h, and subsequently, their 
oxidative status was analyzed using a DakoCytomation CyAn multilaser flow cytometer (Northwestern 
University Flow Cytometry Core Facility) using 400 nm and 485 nm excitation wavelengths, while 
emission was assessed at 535 nm, as previously described [23]. For each condition, the cysteine thiol 
redox status was calculated as percent oxidized, by comparison to values obtained for the fully reduced 
and fully oxidized conditions. 
4.4. Soluble Guanylate Cyclase Activity Assay 
PASMC were harvested using 1× Mg-lysis buffer (Upstate, Charlottesville, VA, USA) along with 
protease inhibitor (Sigma) and phosphatase inhibitor (EMD Biosciences, San Diego, CA, USA) as 
previously described [23]. Cell extracts were sonicated, and protein concentration was determined 
using the Bradford assay [26]. sGC activity was measured as previously described, and cGMP 
production was measured as described above in the presence of IBMX, a non-specific 
phosphodiesterase inhibitor [27]. In brief, 30 µg of total protein was incubated with a previously 
described incubation buffer containing TrisHCl (0.5 M, pH 7.5, Fisher Scientific, Pittsburgh, PA, 
USA), MgCl (80 mM, Fisher), IBMX (2 mM, Enzo Life Sciences, Farmingdale, NY, USA), creatinine 
phosphate (150 mM, Sigma), creatinine phosphokinase (5 mg/mL, Sigma), GTP (10 mM, Sigma), and 
sodium nitroprusside (10 mM, Sigma) for 10 min at 37 °C. The reaction was terminated by adding  
ice-cold HCl (0.05 N, Sigma). Precipitate was removed by centrifugation at 2000 × g for 15 min. The 
extracts were dried, and the pellet was re-suspended in EIA buffer (Cayman Chemical, Ann Arbor, MI, 
USA) as previously described and acetylated according to the manufacturer’s protocol [23]. cGMP 
content was measured in duplicate, and results were measured using a Labsystems Multiskan EX 
automated plate reader (Thermo Electron, Pittsburgh, PA, USA) at 420 nm. sGC activity is shown as 
pmol cGMP produced per mg of total protein per min. 
4.5. Western Blot Analysis 
PASMC were harvested using 1× Mg-lysis buffer, cell extracts were sonicated, and protein 
concentration determined as described above. Total protein (40 µg) was used to perform Western blots 
as previously published [23]. Membranes were incubated overnight at 4 °C with primary antibody in 
5% milk in 1X TBST at an appropriate dilution (1:500 for rabbit anti-sGCβ [Calbiochem], 1:333 for 
mouse anti-PDE5 [BD Transduction, San Jose, CA, USA], 1:5000 for mouse β-actin [Sigma] and 
1:250 for rabbit anti-iNOS [BD Transduction]). The membranes were washed and incubated for 1–2 h 
with the appropriate secondary antibody conjugated to horseradish peroxidase diluted to 1:1000. 
Membranes were washed again and exposed via chemiluminesence (Pierce, Rockford, IL, USA). 
Bands were analyzed using a Digital Science Image Station (Kodak, Rochester, NY, USA). sGCβ or 
iNOS expression within each western blot was normalized to β-actin. Data are shown as fold relative 
to untreated static PASMC. 
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4.6. cGMP Enzyme Linked Immunoassay 
PASMC steady state cGMP content was measured by enzyme linked immunoassay in duplicate 
using a commercially available kit (Cayman Chemical) as previously described [23]. Results are 
shown as pmol cGMP per mg protein for PASMC samples. 
4.7. PDE5 Activity Assay 
PASMCs were harvested, and protein was prepared as described above. Free phosphate was 
removed from protein extracts by passing extracts over a Centri-Spin 10 column (Princeton 
Separations, Adelphia, NJ, USA). Protein concentration was determined using the Bradford method. 
Total protein (5 µg) was assayed for cGMP hydrolytic activity using a commercially available 
colorimetric cyclic nucleotide phosphodiesterase assay kit (Enzo, Farmingdale, NY, USA) with and 
without sildenafil (Sigma) as described previously [23]. Results are shown as the PDE5- specific pmol 
cGMP hydrolyzed per mg total protein per min. 
4.8. iNOS mRNA Expression  
PASMC were harvested for RNA utilizing the Aurum Total RNA Mini Kit (BioRad, Hercules, CA, 
USA), and RNA was quantified using the Quant-it RiboGreen assay (Molecular Probes/Invitrogen, 
Carlsbad, CA, USA). cDNA was prepared from total RNA utilizing the iScript cDNA Synthesis Kit 
(BioRad). Real-time PCR was performed using the iQ SYBR Green Supermix (BioRad) with the 
iCycler iQ real-time PCR detection system (BioRad) with 38 cycles of real-time data collection using 
95 °C for 10 s and 60.5 °C for 45 s, followed by melt curve analysis to verify the presence of a single 
product. Primers were designed using commercially available software and are based on ovis aries 
iNOS mRNA accession number AF223942.1: forward 5'-TGAGAATGGCAGCTACTGGGTCAA and 
reverse 5'-TGGTGATGTCCAGGAAATGGGTGA. Relative iNOS amounts were normalized to  
β-actin expression using the CT method [28].  
4.9. Statistical Analysis 
All data are expressed as the mean ± SEM. Results were analyzed by student’s t-test or one-way 
ANOVA with post-hoc Bonferroni’s analysis as appropriate using Graphpad Prism (San Diego, CA, 
USA). Statistical significance was set at p < 0.05. 
5. Conclusions  
In conclusion, cyclic stretch increases sGC expression and activity in an iNOS-dependent manner in 
fetal PASMC. The mechanism is not yet known, but does not appear to involve activation by ROS. 
The increase in sGC expression and activity may represent an early compensatory mechanism to 
counteract the effects of stretch-induced oxidative stress. This compensation may be lost over time 
with ongoing cyclic stretch and/or stretch-induced oxidative injury. Therefore, a better understanding 
of how to preserve sGC activity as well as a better understanding of the interplay between  
Int. J. Mol. Sci. 2013, 14 4346 
 
 
stretch-mediated oxidative injury and the iNOS-sGC pathway in PASMC could provide key insights 
into future avenues to treat infants with pulmonary hypertension. 
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